AXSM
Axsome Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website axsome.com
- Employees(FY) 502
- ISIN US05464T1043
Performance
+3.88%
1W
+11.23%
1M
-17.53%
3M
+28.19%
6M
-3.83%
YTD
-2.48%
1Y
Profile
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that is in Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial of for treating attention-deficit/hyperactivity disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Investment Analysis Report: AXSM
Overview
In this investment analysis report, we will delve into a comprehensive analysis of AXSM, a company operating in the Health Technology sector within the Biotechnology industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow...
Technical Analysis of AXSM 2024-05-10
Overview:
In analyzing the technical indicators for AXSM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the m...
Recent News & Updates
- 2024-05-18 06:47
3 Monster Stocks in the Making You Can Buy Right Now(Motley Fool)
- 2024-05-13 19:57
15 Most Depressed States in the US(Insider Monkey)
- 2024-05-11 10:00
The 3 Most Undervalued Biotech Stocks to Buy in May 2024(InvestorPlace)
- 2024-05-10 22:00
The 3 Most Undervalued Biotech Stocks to Buy in May 2024(Investorplace)
- 2024-05-10 21:00
Prediction: These 2 Growth Stocks Could Triple By 2030(Yahoo Finance)
- 2024-05-09 06:15
- 2024-05-08 07:00
- 2024-05-07 19:00
- 2024-05-07 11:26
- 2024-05-07 11:17
- 2024-05-07 03:01
- 2024-05-06 23:26
- 2024-05-06 22:55
Q1 2024 Axsome Therapeutics Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-06 13:00
- 2024-05-06 07:00
- 2024-05-06 00:53
- 2024-05-05 19:00
- 2024-05-03 08:30
- 2024-05-02 20:30
- 2024-05-01 07:00
- 2024-04-30 19:00
- 2024-04-30 15:20
- 2024-04-30 03:20
- 2024-04-29 04:01
- 2024-04-28 22:00
- 2024-04-22 09:16
15 Most Black States in the US(Insider Monkey)
- 2024-04-21 21:16
15 Most Black States in the US(Insidermonkey)
- 2024-04-15 07:00
- 2024-04-14 19:00
- 2024-04-10 07:00
Page 1 of 7
previousnext